Scholar Rock Holding buy RudolfL
Start price
14.06.21
/
50%
€25.60
Target price
14.06.22
€32.00
Performance (%)
-32.03%
End price
17.01.22
€17.40
Summary
This prediction ended on 17.01.22 with a price of €17.40. The BUY prediction by RudolfL for Scholar Rock Holding performed very badly with a performance of -32.03%. RudolfL has a follow-up prediction for Scholar Rock Holding where he still thinks Scholar Rock Holding is a Buy. RudolfL has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Scholar Rock Holding | -0.758% | -0.758% | 103.101% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% |
Comments by RudolfL for this prediction
In the thread Scholar Rock Holding diskutieren
In the thread Trading Scholar Rock Holding
Current prediction by RudolfL for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€14.90
06.02.24
06.02.24
€19.00
26.05.24
26.05.24
-12.08%
18.04.24
18.04.24
Stopped prediction by RudolfL for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€9.05
22.08.22
22.08.22
€11.00
22.08.23
22.08.23
-31.49%
23.08.23
23.08.23